QPMind

QMind is a new kind of biotech company – the first biotech company to apply the combination of AI with Quantitative Systems Pharmacology (QSP), a sophisticated method of biological modeling, to drive the drug discovery process de novo with a platform approach for central nervous system (CNS) diseases. QPMind has a lead in Alzheimer's disease complemented by a small pipeline of other targets and diseases, among which chronic pain.